Drug: alkeran Quarter: 2016Q3
Total Records: 109 Number of Pages: 6
| DRUGNAME | PT | EventCount |
|---|---|---|
| ALKERAN | International normalised ratio increased | 1 |
| ALKERAN | Interstitial lung disease | 1 |
| ALKERAN | Intestinal obstruction | 1 |
| ALKERAN | Liver disorder | 1 |
| ALKERAN | Lung disorder | 1 |
| ALKERAN | Lung infiltration | 1 |
| ALKERAN | Lymphoma | 1 |
| ALKERAN | Meningioma | 1 |
| ALKERAN | Multiple organ dysfunction syndrome | 1 |
| ALKERAN | Myelodysplastic syndrome | 1 |
| ALKERAN | Neutropenic colitis | 1 |
| ALKERAN | Peripheral sensory neuropathy | 1 |
| ALKERAN | Pinealoblastoma | 1 |
| ALKERAN | Plasma cell myeloma | 1 |
| ALKERAN | Pleural effusion | 1 |
| ALKERAN | Primary hypothyroidism | 1 |
| ALKERAN | Primary myelofibrosis | 1 |
| ALKERAN | Product use issue | 1 |
| ALKERAN | Pulmonary congestion | 1 |
| ALKERAN | Rash erythematous | 1 |
Total Records: 109 Number of Pages: 6